NovaBridge Biosciences (NBP) Treasury Shares (2017 - 2025)
NovaBridge Biosciences (NBP) reported Treasury Shares of -$5.0 million for Q4 2025, up 19.0% year-over-year from -$4.2 million in Q4 2024, and up 3.74% quarter-over-quarter from -$5.2 million in Q3 2025.
NovaBridge Biosciences (NBP) Treasury Shares (2017 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has 5 years of Treasury Shares data on file, last reported at -$5.0 million in Q4 2025.
- Treasury Shares for Q4 2025 came in at -$5.0 million, up 19.0% year-over-year; the trailing twelve-month figure through Dec 2025 was -$5.0 million (up 19.0% YoY), and the FY2025 annual result was -$5.0 million, up 19.0% from the prior year.
- Treasury Shares advanced to -$5.0 million in Q4 2025 per NBP's latest filing, from -$5.2 million in the prior quarter.
- Over five years, Treasury Shares peaked at $2.9 million in Q4 2025 and troughed at $231766.3 in Q4 2021.
- A 4-year average of $1.2 million and a median of $856224.2 in 2022 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2023 and 2024: Treasury Shares jumped 164.06% in 2023, then tumbled 178.91% in 2024.
- A 4-year view of Treasury Shares shows it stood at $3.0 million in 2022, then jumped by 164.06% to $7.9 million in 2023, then slumped by 178.91% to -$6.2 million in 2024, then gained by 19.0% to -$5.0 million in 2025.
- Business Quant data shows NBP's Treasury Shares at -$5.0 million in Q4 2025, -$5.2 million in Q3 2025, and -$5.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | NovaBridge Biosciences | 328.19 Mn | 117.34 Mn | - | 2.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.86 Mn |
| Dec 31, 2025 | -5.04 Mn |
| Dec 31, 2025 | -5.04 Mn |
| Dec 31, 2025 | 2.86 Mn |
| Sep 30, 2025 | -5.24 Mn |
| Sep 30, 2025 | -5.24 Mn |
| Jun 30, 2025 | -5.61 Mn |
| Jun 30, 2025 | -5.61 Mn |
| Mar 31, 2025 | -5.88 Mn |
| Mar 31, 2025 | -5.88 Mn |
| Dec 31, 2024 | -6.23 Mn |
| Dec 31, 2024 | -6.23 Mn |
| Sep 30, 2024 | -6.23 Mn |
| Sep 30, 2024 | -6.23 Mn |
| Jun 30, 2024 | -6.37 Mn |
| Jun 30, 2024 | -6.37 Mn |
| Dec 31, 2023 | 7.89 Mn |
| Dec 31, 2023 | 7.89 Mn |
| Dec 31, 2023 | 1.48 Mn |
| Dec 31, 2023 | 1.48 Mn |